Article

CMS increases reimbursement for two spherical aberration-reducing lenses

Baltimore-The Centers for Medicare and Medicaid Services (CMS) has awarded new technology IOL (NTIOL) status to two lenses designed to reduce spherical aberrations (SofPort Advanced Optics, SofPort Advanced Optics with Violet Shield, Bausch & Lomb).

Baltimore-The Centers for Medicare and Medicaid Services (CMS) has awarded new technology IOL (NTIOL) status to two lenses designed to reduce spherical aberrations (SofPort Advanced Optics, SofPort Advanced Optics with Violet Shield, Bausch & Lomb). To garner NTIOL designation, both lenses showed the same or better clinical benefit as the lens that set up the NTIOL subset.

Based on this new designation, Medicare will increase by $50 its reimbursement to ambulatory surgery centers for cataract procedures performed with either lens. The increased payment will be effective until Feb. 26, 2011.

“Achievement of NTIOL designation validates Bausch & Lomb’s IOL development program and demonstrates our continued commitment to providing cataract surgeons with products that enhance the quality of the lives of their patients,” said Henry C. Tung, MD, Bausch & Lomb vice president–global surgical.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.